Responses In Patients With Braf V600-Mutant Metastatic Melanoma Receiving Anti-Pd1/Pdl1 Therapy Alone Or Combined With Braf Inhibitors.

Edelyn Barcena,VanAnh Trinh,Susan McIntyre,Rinata Simien,Suzanne Cain,Adi Diab,Rodabe N. Amaria,Sapna Pradyuman Patel,Isabella C. Glitza,Hussein Abdul-Hassan Tawbi,Michael A. Davies,Wen-Jen Hwu

JOURNAL OF CLINICAL ONCOLOGY（2016）

引用 2|浏览6

暂无评分

摘要

9546Background: Whether anti-PD1/PDL1 (anti-PD) therapy alone, or anti-PD combined with BRAF inhibitors (BRAFi) represents the best treatment for patients (pts) with BRAF V600-mutant metastatic mel...

查看译文

关键词

metastatic melanoma,anti-pd1/pdl1 therapy,braf inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要